Second operation is not related to psychological outcome in breast cancer patients
✍ Scribed by Brenda L. Den Oudsten; Guus L. Van Heck; Alida F.W. Van der Steeg; Jan A. Roukema; Jolanda De Vries
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- French
- Weight
- 205 KB
- Volume
- 126
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
To examine the effect of multiple surgical treatments on psychological outcomes in women with early stage breast cancer (BC) in a prospective follow‐up study. Questionnaires for depressive symptoms (CES‐D), fatigue (FAS), anxiety (STAI‐State), physical health (WHOQOL‐100), psychological health (WHOQOL‐100) and overall quality of life and general health (WHOQOL‐100) were completed before diagnosis (Time‐1) and 1 (Time‐2), 3 (Time‐3), 6 (Time‐4) and 12 (Time‐5) months after the last surgical treatment. From the 217 participating women with early stage BC, 78 (35.9%) needed an additional surgical treatment. Using general linear model (repeated measures), psychosocial outcomes over time were investigated for the breast conserving therapy and mastectomy group, accounting for type of surgery, disease stage and hormonal therapy. Psychological outcomes did not significantly change over time, with the exception of anxiety [Wilks' Lambda = 0.72, F (4,86) = 8.55, p < 0.0001, partial eta squared = 0.29]. On average, women with 1 and women with 2 surgical treatments did not differ on any outcome measure. No interaction effects were found, indicating that changes in outcomes over time were the same for both groups. Women who had a repeat surgical treatment did not score differently on psychological outcome measures compared with women who were treated “efficiently.”
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND: Sentinel lymph node (SLN) biopsy has been well‐established for axillary lymph node staging for patients with breast cancer. For lymph node‐negative patients, planned “backup” axillary lymph node dissection (ALND) is rarely indicated. Among patients with negative SLNs, th
## Abstract Hypoxia is common in many solid tumours, including breast cancer. Hypoxia triggers the expression of hypoxia inducible factor‐1α (HIF‐1α), and HIF‐1α has been associated with an impaired prognosis in breast cancer and down‐regulation of the oestrogen receptor (ER), potentially affecting